Join us at CPHI KOREA! Meet our expert to learn more about our innovative clinical research solutions. Discover how our comprehensive services can support your clinical trials from start to finish, ensuring high-quality outcomes and operational excellence. Don't miss the chance to connect with us and explore how we can help you achieve your clinical research goals. #CPHI #CPHIKorea #OPIS
OPIS
Forschungsdienstleistungen
Desio, Monza Brianza 67.053 Follower:innen
A Science Driven Biotech Focused CRO
Info
OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a Global clinical CRO with 25 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical devices studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceutical, and food supplement studies. Our qualified, fully trained, and dedicated staff has managed more than 1470 studies. OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high quality project execution, with global coverage. Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, dermatology, endocrinology, gastroenterology, gene therapy, hematology, genetic diseases, hepatology, immunology, infectious diseases, musculoskeletal, dietary supplements, metabolism and nutrition disorders, nephrology, neurology, onco-hematology, ophthalmology, respiratory diseases, rare diseases, urogenital disorders and vaccines. OPIS is committed to continuous growth and expansion, while currently we have affiliates in 18 countries around the world. For more information, visit www.opisresearch.com For Employment and Careers, visit www.opisresearch.com/opis-career/
- Website
-
www.opisresearch.com
Externer Link zu OPIS
- Branche
- Forschungsdienstleistungen
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Desio, Monza Brianza
- Art
- Privatunternehmen
- Gegründet
- 1998
- Spezialgebiete
- Clinical Research, CRO, Clinical Development, Early phase trials, Post market studies, Observational research, Real world evidence studies, investigator initiated trials, medical device clinical investigations, nutraceutical studies, medical affairs and medical writing, Regulatory, Trials Start-Up, Data Management, Pharmacovigilance, Quality Assurance, e-Clinical Platform, Project Control, Statistical Analysis and Consultancy, Staudy Management and Monitoring, Preclinical and Drug Development Consultancy, Medical Monitoring, Medical Feasibility und Other Services
Orte
Beschäftigte von OPIS
Updates
-
Today, on World Lung Cancer Day, we at OPIS are proud to be at the forefront of lung cancer research, having managed over 60 studies in this critical area. This represents approximately 15% of our total experience in oncology, where we have conducted over 400 studies. Our ongoing trials play a vital role in developing groundbreaking treatments and enhancing outcomes for lung cancer patients worldwide. Join us in raising awareness and supporting our mission to make a meaningful impact in the fight against lung cancer. Discover more about our experience at www.opisresearch.com #WorldLungCancerDay #LungHealth #ClinicalTrials #Research #OPIS
-
BIO Asia–Taiwan 2024 concluded with great success! Our booth was a hub of insightful conversations and meaningful connections. We were delighted to showcase our expertise and engage with industry leaders. A special shoutout to our experts, Alan Syu and SHIHHUNG CHOU, for representing #OPIS with such professionalism and enthusiasm. Thank you to everyone who stopped by and made this experience so enriching. We look forward to continuing these exciting conversations and collaborations. #BioAsia2024 #BioAsia #BioTaiwan #CRO #ClinicalDevelopment
-
Join #OPIS at BIO Asia–Taiwan! Visit our booth #L524 to meet our clinical trial experts, SHIHHUNG CHOU and Alan Syu. Engage in insightful discussions, learn about our innovative approaches, and explore opportunities for collaboration. We look forward to meeting you there! #BIOAsiaTaiwan #BIOAsiaTaiwan2024 #ClinicalDevelopment
-
The 11th annual Outsourcing in Clinical Trials UK & Ireland is just around the corner, and hashtag #OPIS is excited to be part of it! Ready to network, hear from industry experts, and explore the latest innovations and regulatory updates? Don’t miss the chance to connect with our director, Gary, and discover how OPIS is leading the way in clinical trial advancements. Schedule a meeting with Gary Quashie ➡ https://lnkd.in/dWYCii6t hashtag #OCT #OCT2024 #OCTUK #OCTIreland Outsourcing in Clinical Trials Event Series
-
Meet our team at #BIO2024 in San Diego! Step by our booth at #4602 and uncover the keys to successful clinical trials! We are excited to present our cutting-edge solutions, designed specifically for your clinical trials! Explore our innovations firsthand and see how OPIS can elevate your clinical research. Don't miss this opportunity to explore the future of healthcare with #OPIS #BIOInternationalConvention Biotechnology Innovation Organization
-
Gary, Elena, Mila, SHIHHUNG CHOU and Rio Park represented #OPIS with excellence at #ASCO2024. We thank everyone who visited our booth #10095 and engaged in insightful conversations about the latest developments in cutting-edge oncological therapies. From groundbreaking clinical research to innovative treatments, our commitment to fostering unparalleled solutions in cancer care remains steadfast. Thank you for connecting with us and helping shape the future of oncology! We look forward to continued collaboration and innovation. #ASCO
-
Join us at booth nr 4602 and meet our team of experts: Magdalena, Changsook, Gary, Thomas, Jennifer, Alessandro, SHIHHUNG, Alan at the BIO International Convention 2024! Discover our innovative approaches and unlock new collaboration opportunities in the clinical trial field. Let's drive innovation forward together! #BIO2024 #BioInternationalConvention Biotechnology Innovation Organization
-
Make sure to stop by our booth #10095 at the #ASCO Annual Meeting! We are excited to connect with you and discuss the latest developments in clinical research. Meet our Vice President, Giovanni Trolese, along with our team members Gary Quashie, Elena Ravasi, SHIHHUNG CHOU, Rio Park, and Mila Grujičić. Join us for insightful conversations and networking opportunities! We can't wait to see you there! #ASCO2024 American Society of Clinical Oncology (ASCO)
-
The BIO KOREA International Convention was an incredible success! It was a pleasure connecting with everyone who visited our booth, #G23. Our #OPIS team engaged in insightful discussions and exchanged ideas on the latest advancements in the bio-health industry. A heartfelt thank you to all who stopped by and contributed to the enriching experience at this conference. We look forward to seeing you again next year! #BioKorea2024 #COEX #biokorea